Tilray Brands (TLRY) Sales of Property, Plant and Equipment (2017 - 2026)

Tilray Brands (TLRY) Sales of Property, Plant and Equipment (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 10.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 344,333.70
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 1.60 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Tilray Brands 454.65 Mn 394.45 Mn 54.95 Mn 1.37 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 1.37 Mn
Feb 28, 2026 1.37 Mn
Nov 30, 2025 134,000.00
Nov 30, 2025 134,000.00
Aug 31, 2025 293,000.00
Aug 31, 2025 293,000.00
May 31, 2025 5.99 Mn
May 31, 2025 5.99 Mn
Feb 28, 2025 202,000.00
Feb 28, 2025 202,000.00
Nov 30, 2024 603,000.00
Nov 30, 2024 603,000.00
Aug 31, 2024 28,000.00
Aug 31, 2024 28,000.00
May 31, 2024 7.34 Mn
May 31, 2024 7.34 Mn
Feb 29, 2024 801,000.00
Feb 29, 2024 801,000.00
Nov 30, 2023 23,000.00
Nov 30, 2023 23,000.00